US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist
  • 23.090
  • +0.340+1.49%
Close May 15 16:00 ET
  • 23.200
  • +0.110+0.48%
Pre 06:13 ET
17.15BMarket Cap-67.91P/E (TTM)

Summit Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
57.71%66.85M
-62.94%225.97M
-85.53%80.59M
184.88%58.38M
182.45%44.61M
161.03%42.39M
847.80%609.69M
4,609.32%557.16M
19.42%20.49M
22.18%15.79M
Selling and administrative expenses
35.34%15.59M
99.67%60.5M
24.12%14.41M
275.23%20.39M
121.20%13.97M
65.94%11.52M
13.30%30.3M
53.21%11.61M
-2.49%5.43M
-8.90%6.32M
-General and administrative expense
35.34%15.59M
99.67%60.5M
24.12%14.41M
275.23%20.39M
121.20%13.97M
65.94%11.52M
13.30%30.3M
53.21%11.61M
-2.49%5.43M
-8.90%6.32M
Research and development costs
66.05%51.27M
-71.44%165.78M
-87.83%66.39M
146.19%37.72M
225.87%30.8M
212.38%30.87M
1,016.15%580.39M
10,032.36%545.73M
-10.12%15.32M
4.92%9.45M
Other taxes
----
66.91%-313K
-15.17%-205K
199.62%264K
-507.69%-159K
60.70%-213K
79.08%-946K
77.55%-178K
78.35%-265K
104.81%39K
Other operating expenses
----
----
----
----
----
----
99.44%-55K
99.71%-1K
----
99.46%-12K
Operating profit
-57.71%-66.85M
62.94%-225.97M
85.53%-80.59M
-184.88%-58.38M
-182.45%-44.61M
-161.03%-42.39M
-858.31%-609.69M
-4,609.32%-557.16M
-20.97%-20.49M
-24.44%-15.79M
Net non-operating interest income expense
0
178.90%4.78M
79.28%13.46M
9.81%-2.46M
-23.34%-3.1M
62.52%-3.12M
-109.76%-6.06M
639.61%7.51M
-293.35%-2.72M
-285.15%-2.52M
Non-operating interest income
----
29.44%13.47M
----
----
----
----
587.57%10.4M
----
----
----
Non-operating interest expense
--0
-47.23%8.69M
-99.69%9K
-9.81%2.46M
23.34%3.1M
-62.52%3.12M
274.03%16.46M
-0.24%2.9M
293.35%2.72M
285.15%2.52M
Other net income (expense)
93.32%3.94M
-112.44%-97K
-98.84%5.96M
135.30%4.58M
-452.81%-12.67M
100.39%2.04M
106.36%780K
8,640.90%513.05M
151.85%1.95M
204.85%3.59M
Gain on sale of security
93.32%3.94M
-109.40%-97K
-16.60%-9.05M
127.81%4.58M
-35.11%2.33M
-24.22%2.04M
125.12%1.03M
-457.23%-7.76M
152.91%2.01M
205.42%3.6M
Special income (charges)
----
--0
-97.12%15.01M
--0
---15.01M
--0
--0
6,251.57%520.92M
--0
--0
-Less:Impairment of capital assets
----
--0
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
----
----
----
--15.01M
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
----
-182.89%-252K
-135.99%-104K
-239.13%-64K
64.29%-5K
Income before tax
-44.72%-62.91M
64.02%-221.29M
-67.14%-61.18M
-164.50%-56.25M
-310.31%-60.39M
91.98%-43.47M
-680.59%-614.96M
-90.35%-36.6M
0.55%-21.27M
12.25%-14.72M
Income tax
Net income
-44.72%-62.91M
64.02%-221.29M
-67.14%-61.18M
-164.50%-56.25M
-310.31%-60.39M
91.98%-43.47M
-680.59%-614.96M
-90.35%-36.6M
0.55%-21.27M
12.25%-14.72M
Net income continuous Operations
-44.72%-62.91M
64.02%-221.29M
-67.14%-61.18M
-164.50%-56.25M
-310.31%-60.39M
91.98%-43.47M
-680.59%-614.96M
-90.35%-36.6M
0.55%-21.27M
12.25%-14.72M
Minority interest income
Net income attributable to the parent company
-44.72%-62.91M
64.01%-221.32M
-67.37%-61.2M
-164.50%-56.25M
-310.31%-60.39M
91.98%-43.47M
-680.54%-614.93M
-90.17%-36.57M
0.55%-21.27M
12.25%-14.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-44.72%-62.91M
64.01%-221.32M
-67.37%-61.2M
-164.50%-56.25M
-310.31%-60.39M
91.98%-43.47M
-680.54%-614.93M
-90.17%-36.57M
0.55%-21.27M
12.25%-14.72M
Basic earnings per share
-50.00%-0.09
68.69%-0.31
-800.00%-0.09
-166.67%-0.08
-350.00%-0.09
95.80%-0.06
-141.46%-0.99
75.00%-0.01
70.00%-0.03
83.33%-0.02
Diluted earnings per share
-50.00%-0.09
68.69%-0.31
-800.00%-0.09
-166.67%-0.08
-350.00%-0.09
95.80%-0.06
-141.46%-0.99
75.00%-0.01
70.00%-0.03
83.33%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 57.71%66.85M-62.94%225.97M-85.53%80.59M184.88%58.38M182.45%44.61M161.03%42.39M847.80%609.69M4,609.32%557.16M19.42%20.49M22.18%15.79M
Selling and administrative expenses 35.34%15.59M99.67%60.5M24.12%14.41M275.23%20.39M121.20%13.97M65.94%11.52M13.30%30.3M53.21%11.61M-2.49%5.43M-8.90%6.32M
-General and administrative expense 35.34%15.59M99.67%60.5M24.12%14.41M275.23%20.39M121.20%13.97M65.94%11.52M13.30%30.3M53.21%11.61M-2.49%5.43M-8.90%6.32M
Research and development costs 66.05%51.27M-71.44%165.78M-87.83%66.39M146.19%37.72M225.87%30.8M212.38%30.87M1,016.15%580.39M10,032.36%545.73M-10.12%15.32M4.92%9.45M
Other taxes ----66.91%-313K-15.17%-205K199.62%264K-507.69%-159K60.70%-213K79.08%-946K77.55%-178K78.35%-265K104.81%39K
Other operating expenses ------------------------99.44%-55K99.71%-1K----99.46%-12K
Operating profit -57.71%-66.85M62.94%-225.97M85.53%-80.59M-184.88%-58.38M-182.45%-44.61M-161.03%-42.39M-858.31%-609.69M-4,609.32%-557.16M-20.97%-20.49M-24.44%-15.79M
Net non-operating interest income expense 0178.90%4.78M79.28%13.46M9.81%-2.46M-23.34%-3.1M62.52%-3.12M-109.76%-6.06M639.61%7.51M-293.35%-2.72M-285.15%-2.52M
Non-operating interest income ----29.44%13.47M----------------587.57%10.4M------------
Non-operating interest expense --0-47.23%8.69M-99.69%9K-9.81%2.46M23.34%3.1M-62.52%3.12M274.03%16.46M-0.24%2.9M293.35%2.72M285.15%2.52M
Other net income (expense) 93.32%3.94M-112.44%-97K-98.84%5.96M135.30%4.58M-452.81%-12.67M100.39%2.04M106.36%780K8,640.90%513.05M151.85%1.95M204.85%3.59M
Gain on sale of security 93.32%3.94M-109.40%-97K-16.60%-9.05M127.81%4.58M-35.11%2.33M-24.22%2.04M125.12%1.03M-457.23%-7.76M152.91%2.01M205.42%3.6M
Special income (charges) ------0-97.12%15.01M--0---15.01M--0--06,251.57%520.92M--0--0
-Less:Impairment of capital assets ------0------------------0------------
-Less:Other special charges ------------------15.01M--------------------
Other non- operating income (expenses) -------------------------182.89%-252K-135.99%-104K-239.13%-64K64.29%-5K
Income before tax -44.72%-62.91M64.02%-221.29M-67.14%-61.18M-164.50%-56.25M-310.31%-60.39M91.98%-43.47M-680.59%-614.96M-90.35%-36.6M0.55%-21.27M12.25%-14.72M
Income tax
Net income -44.72%-62.91M64.02%-221.29M-67.14%-61.18M-164.50%-56.25M-310.31%-60.39M91.98%-43.47M-680.59%-614.96M-90.35%-36.6M0.55%-21.27M12.25%-14.72M
Net income continuous Operations -44.72%-62.91M64.02%-221.29M-67.14%-61.18M-164.50%-56.25M-310.31%-60.39M91.98%-43.47M-680.59%-614.96M-90.35%-36.6M0.55%-21.27M12.25%-14.72M
Minority interest income
Net income attributable to the parent company -44.72%-62.91M64.01%-221.32M-67.37%-61.2M-164.50%-56.25M-310.31%-60.39M91.98%-43.47M-680.54%-614.93M-90.17%-36.57M0.55%-21.27M12.25%-14.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -44.72%-62.91M64.01%-221.32M-67.37%-61.2M-164.50%-56.25M-310.31%-60.39M91.98%-43.47M-680.54%-614.93M-90.17%-36.57M0.55%-21.27M12.25%-14.72M
Basic earnings per share -50.00%-0.0968.69%-0.31-800.00%-0.09-166.67%-0.08-350.00%-0.0995.80%-0.06-141.46%-0.9975.00%-0.0170.00%-0.0383.33%-0.02
Diluted earnings per share -50.00%-0.0968.69%-0.31-800.00%-0.09-166.67%-0.08-350.00%-0.0995.80%-0.06-141.46%-0.9975.00%-0.0170.00%-0.0383.33%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Lennar Corp
LEN
110.110
Adobe
ADBE
404.690
Toll Brothers
TOL
106.380
4
D.R. Horton
DHI
123.390
5
KB Home
KBH
54.390
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀